• The UAB News Studio is available for live or taped HD interviews with UAB experts worldwide through LTN Global Networks.
  • There is no cost to use the studio when using UAB experts.
  • The studio is also equipped with an ISDN line for digital radio interviews.

New research shows that a Phase I clinical trial of influenza vaccine patch may be the future of preventing the nasty virus. A phase 1 clinical trial, the results of which were published in the medical journal Lancet on Tuesday, has deemed the dissolvable microneedle flu patch to be "well tolerated" and safe for possible use.

Instead of receiving a flu vaccine with the typical prick of a syringe, the petite patch comes equipped with 100 microneedles that deliver a vaccine when pressed onto your arm.

Highly-regarded influenza vaccine expert, Kevin Harrod, Ph.D., is available to talk about the applications of this new patch.

MEDIA CONTACT
Register for reporter access to contact details
TYPE OF ARTICLE
Expert Pitch
SECTION
CHANNELS
Infectious Diseases Public Health Vaccines
KEYWORDS
Flu Vaccination Influenza
COMMENTS | COMMENTING POLICY